Liver is able to activate naïve CD8+ T cells with dysfunctional anti-viral activity in the murine system

• Published in: PloS one 2009-10, Vol.4 (10), p.e7619-e7619
• Main Authors: Lukens, John R, Dolina, Joseph S, Kim, Taeg S, Tacke, Robert S, Hahn, Young S
• Format: Article
• Language: English
• Subjects: Adenoviridae - metabolism; Adenoviridae Infections; Animals; Antiviral agents; Antiviral Agents - chemistry; Bacteria; Bone Marrow Cells - cytology; CD8 antigen; CD8-Positive T-Lymphocytes - immunology; CD8-Positive T-Lymphocytes - metabolism; Cell Differentiation; Coculture Techniques; Cytokines; Cytokines - metabolism; Effector cells; Flow Cytometry - methods; Immune response; Immunology/Immune Response; Immunology/Immunity to Infections; Immunology/Immunomodulation; Infections; Inflammation; Intravenous administration; Liver; Liver - metabolism; Lymphocytes; Lymphocytes T; Lymphoid tissue; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; PD-1 protein; Priming; Rodents; Spleen - virology; T cell receptors; Tissues; Vaccination; Viral infections
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0007619

The liver possesses distinct tolerogenic properties because of continuous exposure to bacterial constituents and nonpathogenic food antigen. The central immune mediators required for the generation of effective immune responses in the liver environment have not been fully elucidated. In this report, we demonstrate that the liver can indeed support effector CD8(+) T cells during adenovirus infection when the T cells are primed in secondary lymphoid tissues. In contrast, when viral antigen is delivered predominantly to the liver via intravenous (IV) adenovirus infection, intrahepatic CD8(+) T cells are significantly impaired in their ability to produce inflammatory cytokines and lyse target cells. Additionally, intrahepatic CD8(+) T cells generated during IV adenovirus infection express elevated levels of PD-1. Notably, lower doses of adenovirus infection do not rescue the impaired effector function of intrahepatic CD8(+) T cell responses. Instead, intrahepatic antigen recognition limits the generation of potent anti-viral responses at both priming and effector stages of the CD8(+) T cell response and accounts for the dysfunctional CD8(+) T cell response observed during IV adenovirus infection. These results also implicate that manipulation of antigen delivery will facilitate the design of improved vaccination strategies to persistent viral infection.